Equities

Pulse Biosciences Inc

Pulse Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)18.38
  • Today's Change0.70 / 3.96%
  • Shares traded103.88k
  • 1 Year change+152.82%
  • Beta1.7384
Data delayed at least 15 minutes, as of Nov 25 2024 19:51 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments446129
Total Receivables, Net--00.06
Total Inventory--05.82
Prepaid expenses0.961.012.13
Other current assets, total------
Total current assets456237
Property, plant & equipment, net8.781011
Goodwill, net2.792.792.79
Intangibles, net1.892.553.22
Long term investments------
Note receivable - long term------
Other long term assets0.370.370.37
Total assets597854
LIABILITIES
Accounts payable1.841.572.90
Accrued expenses4.873.495.16
Notes payable/short-term debt000
Current portion long-term debt/capital leases00.920.44
Other current liabilities, total--00.02
Total current liabilities6.715.988.52
Total long term debt0650
Total debt0660.44
Deferred income tax------
Minority interest------
Other liabilities, total8.099.1410
Total liabilities158019
SHAREHOLDERS EQUITY
Common stock0.060.040.03
Additional paid-in capital381292272
Retained earnings (accumulated deficit)(337)(295)(236)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--00
Total equity44(2.25)36
Total liabilities & shareholders' equity597854
Total common shares outstanding553730
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.